Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Long-Term Debt Repayments (2022)

Inspire Medical Systems (INSP) has disclosed Long-Term Debt Repayments for 1 consecutive years, with $21.4 million as the latest value for Q3 2022.

  • Quarterly Long-Term Debt Repayments changed N/A to $21.4 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $21.4 million through Dec 2023, changed 0.0% year-over-year, with the annual reading at $24.5 million for FY2022, N/A changed from the prior year.
  • Long-Term Debt Repayments hit $21.4 million in Q3 2022 for Inspire Medical Systems.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $21.4 million in Q3 2022 to a low of $21.4 million in Q3 2022.